National Peroxide Limited (NPL) has announced the resignation of its Company Secretary and Compliance Officer, marking a significant change in the company's key managerial personnel. The chemical sector company formally notified BSE Limited of this corporate development on December 12, 2025.

Key Personnel Change Details

Mr. Amish Shah, who served as Company Secretary and Compliance Officer, tendered his resignation to pursue alternative career opportunities outside the Wadia Group. The resignation became effective from the closure of business hours on December 12, 2025.

Resignation Communication

In his resignation letter addressed to Mr. Rajiv Arora and Mrs. Surabhi Mittal, Shah expressed gratitude for the opportunities and experiences gained during his tenure. He acknowledged the trust placed in him and appreciated the support and guidance from the leadership team. Shah specifically mentioned that working under the current leadership had been enriching, enabling both professional and personal growth.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. National Peroxide Limited submitted the required intimation to the Corporate Relationship Department of BSE Limited, including detailed annexures as mandated by regulatory guidelines.

Company Information

National Peroxide Limited, formerly known as NPL Chemicals Limited, operates in the chemicals sector with its registered office located at Neville House, J.N. Heredia Marg, Ballard Estate, Mumbai. The notification was signed by Mr. Rajiv Arora, Chief Executive Officer and Director, who holds DIN 08730235.

The resignation represents a routine corporate governance matter, with the company ensuring full compliance with stock exchange listing requirements and maintaining transparency with stakeholders regarding changes in key managerial positions.

NPL , a key player in the hydrogen peroxide manufacturing sector, has reported its financial results for the second quarter and first half of the fiscal year 2025-26, revealing a decline in both revenue and profit compared to the previous year.

Q2 FY26 Performance

For the quarter ended September 30, 2025, NPL recorded:

The company's revenue from operations decreased by 11.3% year-over-year, while profit after tax saw a significant decline of 43.2%.

H1 FY26 Overview

For the half-year ended September 30, 2025:

The company's half-yearly performance also showed a downturn, with revenue decreasing by 10.6% and profit after tax declining sharply by 77.9% compared to the same period last year.

Financial Position

As of September 30, 2025, NPL reported:

• Total Assets: ₹43,969.33 crore
• Equity Share Capital: ₹574.70 crore
• Other Equity: ₹34,351.80 crore

Operational Highlights

NPL continues to operate in a single segment, focusing on the manufacturing of hydrogen peroxide. The company's board of directors approved these unaudited financial results at their meeting held on November 3, 2025.

Market Implications

The decline in revenue and profit may raise concerns among investors about the company's performance in the current economic environment. Factors such as raw material costs, market demand for hydrogen peroxide, and overall industry trends could be influencing these results.

Investors and analysts may want to closely monitor the company's future guidance and any strategic initiatives to address the declining performance in the coming quarters.

NPL continues to be a significant player in the chemical industry, particularly in the hydrogen peroxide segment. The company's ability to navigate current market challenges and return to growth will be crucial for its future performance and market position.